The Chemical Property Position of Bedaquiline Construed by a Chemical Global Positioning System-Natural Product
- PMID: 35164018
- PMCID: PMC8838968
- DOI: 10.3390/molecules27030753
The Chemical Property Position of Bedaquiline Construed by a Chemical Global Positioning System-Natural Product
Abstract
Bedaquiline is a novel adenosine triphosphate synthase inhibitor anti-tuberculosis drug. Bedaquiline belongs to the class of diarylquinolines, which are antituberculosis drugs that are quite different mechanistically from quinolines and flouroquinolines. The fact that relatively similar chemical drugs produce different mechanisms of action is still not widely understood. To enhance discrimination in favor of bedaquiline, a new approach using eight-score principal component analysis (PCA), provided by a ChemGPS-NP model, is proposed. PCA scores were calculated based on 35 + 1 different physicochemical properties and demonstrated clear differences when compared with other quinolines. The ChemGPS-NP model provided an exceptional 100 compounds nearest to bedaquiline from antituberculosis screening sets (with a cumulative Euclidian distance of 196.83), compared with the different 2Dsimilarity provided by Tanimoto methods (extended connective fingerprints and the Molecular ACCess System, showing 30% and 182% increases in cumulative Euclidian distance, respectively). Potentially similar compounds from publicly available antituberculosis compounds and Maybridge sets, based on bedaquiline's eight-dimensional similarity and different filtrations, were identified too.
Keywords: ChemGPS-NP; antituberculosis agents; bedaquiline; chemical property space; data mining; screening; structural similarity.
Conflict of interest statement
The author declares no conflict of interest.
Figures




Similar articles
-
TMC207 becomes bedaquiline, a new anti-TB drug.Future Microbiol. 2013 Sep;8(9):1071-80. doi: 10.2217/fmb.13.85. Future Microbiol. 2013. PMID: 24020736 Review.
-
A review of tuberculosis: Focus on bedaquiline.Am J Health Syst Pharm. 2013 Nov 15;70(22):1984-94. doi: 10.2146/ajhp130199. Am J Health Syst Pharm. 2013. PMID: 24173008 Review.
-
Bedaquiline: a novel antitubercular agent for the treatment of multidrug-resistant tuberculosis.Pharmacotherapy. 2014 Nov;34(11):1187-97. doi: 10.1002/phar.1482. Epub 2014 Sep 9. Pharmacotherapy. 2014. PMID: 25203970 Review.
-
Structural Simplification of Bedaquiline: the Discovery of 3-(4-(N,N-Dimethylaminomethyl)phenyl)quinoline-Derived Antitubercular Lead Compounds.ChemMedChem. 2017 Jan 20;12(2):106-119. doi: 10.1002/cmdc.201600441. Epub 2016 Oct 28. ChemMedChem. 2017. PMID: 27792278 Free PMC article.
-
Bedaquiline: a new hope to treat multi-drug resistant tuberculosis.Curr Top Med Chem. 2014;14(16):1866-74. doi: 10.2174/1568026614666140929114822. Curr Top Med Chem. 2014. PMID: 25262806 Review.
Cited by
-
Capnellenes from Capnella imbricata: Deciphering Their Anti-Inflammatory-Associated Chemical Features.Pharmaceuticals (Basel). 2023 Jun 22;16(7):916. doi: 10.3390/ph16070916. Pharmaceuticals (Basel). 2023. PMID: 37513828 Free PMC article.
-
Review of Marine Cyanobacteria and the Aspects Related to Their Roles: Chemical, Biological Properties, Nitrogen Fixation and Climate Change.Mar Drugs. 2023 Aug 3;21(8):439. doi: 10.3390/md21080439. Mar Drugs. 2023. PMID: 37623720 Free PMC article. Review.
-
Probing Anti-Leukemic Metabolites from Marine-Derived Streptomyces sp. LY1209.Metabolites. 2022 Apr 2;12(4):320. doi: 10.3390/metabo12040320. Metabolites. 2022. PMID: 35448507 Free PMC article.
References
-
- World Health Organization . Global Tuberculosis Report 2012. World Health Organization; Geneva, Switzerland: 2013. [(accessed on 4 June 2014)]. Available online: http://www.who.int/tb/publications/global_report/en/
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous